Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 4, 2003, Pages 1594-1602

  Faraj, May ^a   Havel, Peter J ^c   Phélis, Steve ^a   Blank, David ^b   Sniderman, Allan D ^a   Cianflone, Katherine ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b ROYAL VICTORIA HOSPITAL   (Canada)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLATION STIMULATING PROTEIN; ADIPONECTIN; APOLIPOPROTEIN B; GHRELIN; LEPTIN; LIPID;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; FEMALE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID BLOOD LEVEL; MALE; MORBID OBESITY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; STOMACH BYPASS; WEIGHT REDUCTION;

ADIPONECTIN; ADULT; BLOOD GLUCOSE; BLOOD PROTEINS; COMPLEMENT C3A; FEMALE; GASTRIC BYPASS; HUMANS; INSULIN; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LEPTIN; MALE; MIDDLE AGED; OBESITY, MORBID; PEPTIDE HORMONES; PROTEINS; SEX CHARACTERISTICS;

EID: 0038439261     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2002-021309     Document Type: Article

References (78)

1. Melanson KJ, McInnis KJ, Rippe JM, Blackburn G, Wilson PF 2001 Obesity and cardiovascular disease risk: research update. Cardiol Rev 9:202-207
2. Havel PJ 2001 Peripheral signals conveying metabolic information to the brain: short-term and long-term regulation of food intake and energy homeostasis. Exp Biol Med 226:963-977
3. Horvath TL, Diano S, Sotonyi P, Keiman M, Tschop M 2001 Minireview: ghrelin and the regulation of energy balance-a hypothalamic perspective. Endocrinology 142:4163-4169
4. Schwartz MW 2001 Brain pathways controlling food intake and body weight. Exp Biol Med 226:978-981
5. Schwartz MW, Woods SC, Porte Jr D, Seeley RJ, Baskin DG 2000 Central nervous system control of food intake. Nature 404:661-671
6. Havel PJ 2002 Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acytation stimulating protein, and adiponectin. Curr Opin Lipidol 13:51-59
7. Cianflone K, Roncari DAK, Maslowska M, Baldo A, Forden J, Sniderman AD 1994 The adipsin/acylation stimulating protein system in human adipocytes: regulation of triacylglycerol synthesis. Biochemistry 33:9489-9495
8. Cianflone K, Maslowska M 1995 Differentiation induced production of ASP in human adipocytes. Eur J Clin Invest 25:817-825
9. Sniderman AD, Maslowska M, Cianflone K 2000 Of mice and men (and women) and the acylation-stimulating protein pathway. Curr Opin Lipidol 11:291-296
10. Murray I, Havel PJ, Sniderman AD, Cianflone K 2000 Reduced body weight, adipose tissue, and leptin levels despite increased energy intake in female mice lacking acylation-stimulating protein. Endocrinology 141:1041-1049
11. Maslowska M, Vu H, Phelis S, Sniderman AD, Rhode BM, Blank D, Cianflone K 1999 Plasma acylation stimulating protein, adipsin and lipids in non-obese and obese populations. Eur J Clin Invest 29:679-686
12. Koistinen HA, Vidal H, Karonen SL, Dusserre E, Vallier P, Koivisto VA 2001 Plasma acylation stimulating protein concentration and subcutaneous adipose tissue C3 mRNA expression in nondiabetic and type 2 diabetic men. Arterioscler Throm Vasc Biol. 21:1034-1039
13. Cianflone K, Zhang XJ, Genest Jr J, Sniderman AD 1997 Plasma acylation stimulating protein in coronary artery disease. Arterioscler Thromb Vasc Biol 17:1239-1244
14. Cianflone K, Sniderman AD, Kalant D, Marliss EB, Gougeon R 1995 Response of plasma ASP to a prolonged fast. Int J Obesity 19:604-609
15. Sniderman AD, Cianflone K, Eckel RH 1991 Levels of acylation stimulating protein in obese women before and after moderate weight loss. Int J Obesity 15:333-336
16. Zhang Y, Proenca R, Maffel M, Barone M, Leopold L, Friedman JM 1994 Positional cloning of the mouse obese gene and its human homologue. Nature 372:42-49
17. Camp field LA, Smith FJ, Guisez Y, Devos R, Burn P 1995 Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 269:546-549
18. Flier JS 1998 Clinical review 94: what's in a name? In search of leptins physiologic. J Clin Endocrinol Metab 83:1407-1413
19. Havel PJ 2000 Role of adipose tissue in body-weight regulation: mechanisms regulating leptin production and energy balance. Proc Nutr Soc 59:359-371
20. Keim NL, Stern JS, Havel PJ 1998 Relation between circulating leptin concentrations and appetite during a prolonged, moderate energy deficit in women. Am J Clin Nutr 68:794-801
21. Rosenbaum M, Murphy EM, Heymsfield SB, Matthews DE, Leibel RL 2002 Low dose leptin administration reverses effects of sustained weight-reduction on energy expenditure and circulating concentrations of thyroid hormones. J Clin Endocrinol Metab 87:2391-2394
22. Bai Y, Zhang S, Kim KS, Lee JK, Kim KH 1996 Obese gene expression alters the ability of 30A5 preadipocytes to respond to lipogenic hormones. J Biol Chem 271:13939-13942
23. Wang MY, Lee Y, Unger RH 1999 Novel form of lipolysis induced by leptin. J Biol Chem 274:17541-17544
24. van Dielen FM, van't Veer C, Buurman WA, Greve JW 2002 Leptin and soluble leptin receptor levels in obese and weight-losing individuals. J Clin Endocrinol Metab 87:1708-1716
25. Fruhbeck G, Gomez-Ambrosi J, Muruzabal FJ, Burrell MA 2001 The Adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation. Am J Physiol 280:E827-E847
26. Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, Matsubara K 1996 Cdna cloning and expression of a novel adipose specific collagen-like factor, ap M1 (AdiPose Most abundant Gene transcript 1). Biochem Biophys Res Commun 221:286-289
27. Berg AH, Combs TP, Scherer PE 2002 ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab 13:84-89
28. Kazumi T, Kawaguchi A, Sakai K, Hirano T, Yoshino G 2002 Young men with high-normal blood pressure have lower serumadiponectin, smaller LDL size, and higher elevated heart rate than those withoptimal blood pressure. Diabetes Care 25:971-976
29. Matsubara M, Maruoka S, Katayose S 2002 Decreased plasma adiponectin concentrations in women with dyslipidemia. J Clin Endocrinol Metab 87:2764-2769
30. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA 2001 Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86:1930-1935
31. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K, Nishida M, Kihara S, Sakal N, Nakajima T, Hasegawa K, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Hanafusa T, Matsuzawa Y 2000 Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Throm Vasc Biol 20:1595-1599
32. Stefan N, Vozarova B, Funahashi T, Matsuzawa Y, Weyer C, Lindsay RS, Youngren JF, Havel PJ, Pratley RE, Bogardus C, Tataranni PA 2002 Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans. Diabetes 51:1884-1888
33. Kubota N, Terauchi Y, Yamauchi T, Kubota T, Moroi M, Matsui J, Eto K, Yamashita T, Kamon J, Satoh H, Yano W, Nagai R, Kimura S, Kadowaki T, Noda T 2002 Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem 277:25863-25866
34. Maeda N, Shimomura I, Kishida K, Nishizawa H, Matsuda M, Nagaretani H, Furuyama N, Kondo H, Takahashi M, Arita Y, Komuro R, Ouchi N, Kihara S, Tochino Y, Okutomi K, Horie M, Takeda S, Aoyama T, Funahashi T, Matsuzawa Y 2002 Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med 8:731-737
35. Yang WS, Lee WJ, Funahashi T, Tanaka S, Matsuzawa Y, Chao CL, Chen CL, Tal TY, Chuang LM 2001 Weight reduction increases plasma levels of an adipose-derived antiinfiammatory protein, adiponectin. J Clin Endocrinol Metab 86:3815-3819
36. Kojima M, Hosoda H, Date Y, Nakanzato M, Matsuo H, Kangawa K 1999 Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402:656-660
37. Tschop M, Smiley DL, Heiman ML 2000 Ghrelin induces adiposity in rodents. Nature 407:908-913
38. Wren AM, Seal LJ, Cohen MA, Brynes AE, Frost GS, Murphy KG, Dhillo WS, Ghatei MA, Bloom SR 2001 Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 86:5992
39. Shiiya T, Nakazato M, Mizuta M, Date Y, Mondal MS, Tanaka M, Nozoe S, Hosoda H, Kangawa K, Matsukura S 2002 Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J Clin Endocrinol Metab 87:240-244
40. Hansen TK, Dall R, Hosoda H, Kojima M, Kangawa K, Christiansen JS, Jorgensen JO 2002 Weight loss increases circulating levels of ghrelin in human obesity. Clin Endocrinol (Oxf) 56:203-206
41. Cummings DE, Weigle DS, Frayo RS, Breen PA, Ma MK, Dellinger EP, Purnell JQ 2002 Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 346:1623-1630
42. MacLean LD, Rhode BM, Nohr CW 2000 Late outcome of isolated gastric bypass. Ann Surg 231:524-528
43. MacLean LD, Rhode BM, Nohr CW 2001 Long- or short-limb gastric bypass? J Gastrointest Surg 5:525-530
44. Faraj M, Jones P, Sniderman AD, Cianflone K 2001 Enhanced dietary fat clearance in post-obese women. J Lipid Res 42:571-580
45. Blackburn G, Bistrain B, Maini B, Schlamm H, Smith M 1977 Nutritional and metabolic assessment of the hospitalized patient. J Parenter Enteral Nutr 1:11-22
46. Gidez LI, Miller GJ, Burstein M, Slagle S, Eder HA 1982 Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure. J Lipid Res 23:1206-1223
47. Schectman G, Patsches M, Sasse EA 1996 Variability in cholesterol measurements: comparison of calculated and direct LDL cholesterol determinations. Clin Chem 42:732-737
48. Pagana KD, Pagana TJ 1997 Diagnostic and laboratory test reference, Third Ed. St. Louis: Mosby-Year Book
49. Lipid Research Clinics 1983 Pre-entry characteristics of participants in the Lipid Research Clinics' Coronary Primary Prevention Trial. J Chron Dis 36:467-479
50. Contois JH, McNamara JR, Lammi-Keefe CJ, Wilson PW, Massov T, Schaefer EJ 1996 Reference intervals for plasma apolipoprotein B determined with a standardized commercial immunoturbidimetric assay: results from the Framingham Offspring Study. Clin Chem 42:515-523
51. Saleh J, Summers LKM, Cianflone K, Fielding BA, Sniderman AD, Frayn KN 1998 Coordinated release of acylation stimulating protein (ASP) and triacylglycerol clearance by human adipose tissue in vivo in the postprandial period. J Lipid Res 39:884-891
52. Ma Z, Gingerich RL, Santiago JV, Klein S, Smith CH, Landt M 1996 Radioimmunoassay of leptin in human plasma. Clin Chem 42:942-946
53. Dubuc GR, Phinney SD, Stern JS, Havel PJ 1998 Changes of serum leptin and endocrine and metabolic parameters after 7 days of energy restriction in men and women. Metabolism 47:429-434
54. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC 1985 Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419
55. Rucker Jr RD, Goldenberg F, Varco RL, Buchwald H 1981 Lipid effects of obesity operations. J Surg Res 30:229-235
56. Gonen B, Halverson JD, Schonfeld G 1983 Lipoprotein levels in morbidly obese patients with massive, surgically-induced weight loss. Metab Clin Exp 32:492-496
57. Halverson JD 1992 Metabolic risk of obesity surgery and long-term follow-up. Am J Clin Nutr 55:602S-605S
58. O'Leary JP 1992 Gastrointestinal malabsorptive procedures. Am J Clin Nutr 55:567S-570S
59. Porles WJ, Swanson MS, MacDonald KG, Long SB, Morris PG, Brown BM, Barakat HA, deRamon RA, Israel G, Dolezal JM 1995 Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 222:339-350
60. MacDonald Jr KG, Long SD, Swanson MS, Brown BM, Morris P, Dohm GL, Pories WJ 1997 The gastric bypass operation reduces the progression and mortality of non-insulin-dependent diabetes mellitus. J Gastrointest Surg 1:213-220
61. Gleysteen JJ, Barboriak JJ 1983 Improvement in heart disease risk factors after gastric bypass. Arch Surg 118:681-684
62. Gleysteen JJ 1992 Results of surgery: long-term effects on hyperlipidemia. Am J Clin Nutr 55:591S-593S
63. Gleysteen JJ, Barboriak JJ, Sasse EA 1990 Sustained coronary-risk-factor reduction after gastric bypass for morbid obesity. Am J Clin Nutr 51:774-778
64. Lamarche B, Moorjani S, Lupien PJ, Cantin B, Bernard PM, Dagenais GR, Despres JP 1996 Apoprotein A-1 and B levels and the risk of ischemic heart disease during a 5 year follow-up of men in the Quebec Cardiovascular Study. Circulation 94:273-278
65. Zhang XJ, Cianflone K, Genest J, Sniderman AD 1998 Plasma acylation stimulating protein (ASP) as a predictor of impaired cellular biological response to ASP in patients with hyperapoB. Eur J Clin Invest 28:730-739
66. Sniderman AD, Cianflone K, Frayn K 1997 The pathogenetic role of impaired fatty acid trapping by adipocytes in generating the pleiotropic features of hyperapoB. Diabetologia 40:S152-S154
67. Combs TP, Berg AH, Obici S, Scherer PE, Rossetti L 2001 Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. J Clin Invest 108:1875-1881
68. Maeda N, Takahashi M, Funahashi T, Kihara S, Nishizawa H, Kishida K, Nagaretani H, Matsuda M, Komuro R, Ouchi N, Kuriyama H, Hotta K, Nakamura T, Shimomura I, Matsuzawa Y 2001 PPARγ ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 50:2094-2099
69. Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, Hotta K, Nishida M, Takahashi M, Nakamura T, Yamashita S, Funahashi T, Matsuzawa Y 1999 Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma adiponectin. Circulation 100:2473-2476
70. Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK, Friedman JM 1995 Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269:543-546
71. Wisse BE, Campfield LA, Marliss EB, Morais JA, Tenenbaum R, Gougeon R 1999 Effect of prolonged moderate and severe energy restriction and refeeding on plasma leptin concentrations in obese women. Am J Clin Nutr 70:321-330
72. Scholz GH, Englaro P, Thiele I, Scholz M, Klusmann T, Kellner K, Rascher W, Blum WF 1996 Dissociation of serum leptin concentration and body fat content during long term dietary intervention in obese individuals. Horm Metab Res 28:718-723
73. Havel PJ, Townsend R, Chaump L, Teff K 2001 High-fat meals reduce 24-h circulating leptin concentrations in women. Diabetes 48:334-341
74. Tschop M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E, Heiman ML 2001 Circulating ghrelin levels are decreased in human obesity. Diabetes 50:707-709
75. Cummings DE, Clement K, Purnell JQ, Vaisse C, Foster KE, Frayo RS, Schwartz MW, Basdevant A, Weigle DS 2002 Elevated plasma ghrelin levels in Prader Willi syndrome. Nat Med 8:643-644
76. Saad MF, Bernaba B, Hwu CM, Jinagouda S, Fahmi S, Kogosov E, Boyadjian R 2002 Insulin regulates plasma ghrelin concentration. J Clin Endocrinol Metab 87:3997-4000
77. Gnanapavan S, Kola B, Bustin SA, Morris DG, McGee P, Fairclough P, Bhattacharya S, Carpenter R, Grossman AB, Korbonits M 2002 The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metab 87:2988-2991
78. Saleh J, Blevins JE, Havel PJ, Barrett JA, Gietzen DW, Cianflone K 2001 Acylation stimulating protein (ASP) acute effects on postprandial lipemia and food intake in rodent models. Int J Obesity 25:705-713